Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Leukemia
|
April 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma
Jian Cui, Yuntong Liu, Rui Lv, et al.
Cancer Research Communications
|
September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
Jiahui Liu, Wenqiang Yan, Huishou Fan, et al.
Cancer Research Communications
|
September 18, 2024
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma
Aaron D Springer, Rengang Wang, Jiawei Wang, et al.
Cancers
|
January 10, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States
Jingyu Xu, Meng Shu, Hsingwen Chung, et al.
Translational Oncology
|
August 2, 2011
Antitumor efficacy of a thrombospondin 1 mimetic CovX-body
Lingna Li, Tom A Leedom, Janet Do, et al.
Expert Opinion on Biological Therapy
|
December 11, 2023
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
Reyna Kv Lim, Matthew Buschman, Alisher Khasanov, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 31, 2013
Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody
Jie Huang, Tetsuya Ishino, Gang Chen, et al.
Leukemia
|
August 2, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
Wenqiang Yan, Lihui Shi, Jingyu Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2024
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
Huishou Fan, Bing Wang, Lihui Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2010
Chemical generation of bispecific antibodies
Venkata R Doppalapudi, Jie Huang, Dingguo Liu, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Leukemia
|
April 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma
Jian Cui, Yuntong Liu, Rui Lv, et al.
Cancer Research Communications
|
September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
Jiahui Liu, Wenqiang Yan, Huishou Fan, et al.
Cancer Research Communications
|
September 18, 2024
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma
Aaron D Springer, Rengang Wang, Jiawei Wang, et al.
Cancers
|
January 10, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States
Jingyu Xu, Meng Shu, Hsingwen Chung, et al.
Translational Oncology
|
August 2, 2011
Antitumor efficacy of a thrombospondin 1 mimetic CovX-body
Lingna Li, Tom A Leedom, Janet Do, et al.
Expert Opinion on Biological Therapy
|
December 11, 2023
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
Reyna Kv Lim, Matthew Buschman, Alisher Khasanov, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 31, 2013
Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody
Jie Huang, Tetsuya Ishino, Gang Chen, et al.
Leukemia
|
August 2, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
Wenqiang Yan, Lihui Shi, Jingyu Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2024
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
Huishou Fan, Bing Wang, Lihui Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2010
Chemical generation of bispecific antibodies
Venkata R Doppalapudi, Jie Huang, Dingguo Liu, et al.
Page
of 7